108 related articles for article (PubMed ID: 26574634)
1. CMTM8 is Frequently Downregulated in Multiple Solid Tumors.
Zhang W; Qi H; Mo X; Sun Q; Li T; Song Q; Xu K; Hu H; Ma D; Wang Y
Appl Immunohistochem Mol Morphol; 2017 Feb; 25(2):122-128. PubMed ID: 26574634
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of CMTM8 induces epithelial-to-mesenchymal transition-like changes via c-MET/extracellular signal-regulated kinase (ERK) signaling.
Zhang W; Mendoza MC; Pei X; Ilter D; Mahoney SJ; Zhang Y; Ma D; Blenis J; Wang Y
J Biol Chem; 2012 Apr; 287(15):11850-8. PubMed ID: 22337876
[TBL] [Abstract][Full Text] [Related]
3. Research Advances in Chemokine-like Factor Super Family Member 8.
Gao DH; Hu H; Fang ZW; Huo F; Wang HR; Xu KX; Wang XF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Dec; 38(6):746-749. PubMed ID: 28065246
[TBL] [Abstract][Full Text] [Related]
4. [Expressions of CMTM8 and E-cadherin in primary and metastatic clear cell renal cell carcinoma].
Hu H; Chen JW; Xu KX; Wang D; Wang Y; Wang GW; Zhang SY; Wang XF
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Aug; 45(4):537-41. PubMed ID: 23939157
[TBL] [Abstract][Full Text] [Related]
5. CMTM8 inhibits the carcinogenesis and progression of bladder cancer.
Gao D; Hu H; Wang Y; Yu W; Zhou J; Wang X; Wang W; Zhou C; Xu K
Oncol Rep; 2015 Dec; 34(6):2853-63. PubMed ID: 26503336
[TBL] [Abstract][Full Text] [Related]
6. Functional characterization of the tumor suppressor CMTM8 and its association with prognosis in bladder cancer.
Zhang S; Pei X; Hu H; Zhang W; Mo X; Song Q; Zhang Y; Xu K; Wang Y; Na Y
Tumour Biol; 2016 May; 37(5):6217-25. PubMed ID: 26615421
[TBL] [Abstract][Full Text] [Related]
7. CMTM8 Is a Suppressor of Human Mesenchymal Stem Cell Osteogenic Differentiation and Promoter of Proliferation Via EGFR Signaling.
H'ng CH; Camp E; Anderson PJ; Zannettino ACW; Gronthos S
Stem Cells Dev; 2020 Jul; 29(13):823-834. PubMed ID: 32268840
[TBL] [Abstract][Full Text] [Related]
8. A novel 3p22.3 gene CMTM7 represses oncogenic EGFR signaling and inhibits cancer cell growth.
Li H; Li J; Su Y; Fan Y; Guo X; Li L; Su X; Rong R; Ying J; Mo X; Liu K; Zhang Z; Yang F; Jiang G; Wang J; Zhang Y; Ma D; Tao Q; Han W
Oncogene; 2014 Jun; 33(24):3109-18. PubMed ID: 23893243
[TBL] [Abstract][Full Text] [Related]
9. Downregulated CMTM8 Correlates with Poor Prognosis in Gastric Cancer Patients.
Yan M; Zhu X; Qiao H; Zhang H; Xie W; Cai J
DNA Cell Biol; 2021 Jun; 40(6):791-797. PubMed ID: 33978454
[TBL] [Abstract][Full Text] [Related]
10. CMTM3 inhibits cell growth and migration and predicts favorable survival in oral squamous cell carcinoma.
Zhang H; Zhang J; Nan X; Li X; Qu J; Hong Y; Sun L; Chen Y; Li T
Tumour Biol; 2015 Sep; 36(10):7849-58. PubMed ID: 25946973
[TBL] [Abstract][Full Text] [Related]
11. Cancer Research Advance in CKLF-like MARVEL Transmembrane Domain Containing Member Family (Review).
Lu J; Wu QQ; Zhou YB; Zhang KH; Pang BX; Li L; Sun N; Wang HS; Zhang S; Li WJ; Zheng W; Liu W
Asian Pac J Cancer Prev; 2016; 17(6):2741-4. PubMed ID: 27356683
[TBL] [Abstract][Full Text] [Related]
12. Influence of CMTM8 polymorphisms on lung cancer susceptibility in the Chinese Han population.
Wu J; Sun Y; Xiong Z; Niu F; Liu Y; Li H; Liu J; Wu J; Liu Q; Jin T
Pharmacogenet Genomics; 2021 Jun; 31(4):89-95. PubMed ID: 33395025
[TBL] [Abstract][Full Text] [Related]
13. Research Advances in CKLF-like MARVEL Transmembrane Domain-containing Family in Non-small Cell Lung Cancer.
Wu K; Li X; Gu H; Yang Q; Liu Y; Wang L
Int J Biol Sci; 2019; 15(12):2576-2583. PubMed ID: 31754330
[TBL] [Abstract][Full Text] [Related]
14. Identification and validation of EMT-immune-related prognostic biomarkers CDKN2A, CMTM8 and ILK in colon cancer.
Kang N; Xie X; Zhou X; Wang Y; Chen S; Qi R; Liu T; Jiang H
BMC Gastroenterol; 2022 Apr; 22(1):190. PubMed ID: 35429970
[TBL] [Abstract][Full Text] [Related]
15. CMTM3 is reduced in prostate cancer and inhibits migration, invasion and growth of LNCaP cells.
Hu F; Yuan W; Wang X; Sheng Z; Yuan Y; Qin C; He C; Xu T
Clin Transl Oncol; 2015 Aug; 17(8):632-9. PubMed ID: 25990505
[TBL] [Abstract][Full Text] [Related]
16. An alternative splice form of CMTM8 induces apoptosis.
Li D; Jin C; Yin C; Zhang Y; Pang B; Tian L; Han W; Ma D; Wang Y
Int J Biochem Cell Biol; 2007; 39(11):2107-19. PubMed ID: 17681841
[TBL] [Abstract][Full Text] [Related]
17. [Research advances in CKLF-like MARVEL transmembrane domain containing member 5].
Yuan YQ; Xiao YB; Liu ZH; Zhang XW; Xu T; Wang XF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Dec; 34(6):625-8. PubMed ID: 23286412
[TBL] [Abstract][Full Text] [Related]
18. CMTM4 is frequently downregulated and functions as a tumour suppressor in clear cell renal cell carcinoma.
Li T; Cheng Y; Wang P; Wang W; Hu F; Mo X; Lv H; Xu T; Han W
J Exp Clin Cancer Res; 2015 Oct; 34():122. PubMed ID: 26474560
[TBL] [Abstract][Full Text] [Related]
19. CMTM3 inhibits human testicular cancer cell growth through inducing cell-cycle arrest and apoptosis.
Li Z; Xie J; Wu J; Li W; Nie L; Sun X; Tang A; Li X; Liu R; Mei H; Wang F; Wang Z; Gui Y; Cai Z
PLoS One; 2014; 9(2):e88965. PubMed ID: 24586462
[TBL] [Abstract][Full Text] [Related]
20. CMTM1_v17 is a novel potential therapeutic target in breast cancer.
Wang J; Zhang G; Zhang Y; Luo Y; Song Q; Qiu X; Mo X; Wang L
Oncol Rep; 2014 Nov; 32(5):1829-36. PubMed ID: 25175386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]